Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
99,602,267
-
Share change
-
+29,807,821
-
Total reported value
-
$19,914,335,208
-
Put/Call ratio
-
127%
-
Price per share
-
$199.96
-
Number of holders
-
853
-
Value change
-
+$5,926,918,005
-
Number of buys
-
574
-
Number of sells
-
228
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q4 2020
As of 31 Dec 2020,
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) was held by
853 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
99,602,267 shares.
The largest 10 holders included
VANGUARD GROUP INC, ARK Investment Management LLC, BAILLIE GIFFORD & CO, JENNISON ASSOCIATES LLC, Capital World Investors, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., STATE STREET CORP, BANK OF AMERICA CORP /DE/, and JPMORGAN CHASE & CO.
This page lists
863
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.